Blood test may help identify patients at risk for transthyretin amyloid cardiomyopathy

FHS
July 29, 2023
1:21 am

A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients.

Hospital groups ask Congress to reform 340B program, crack down on contract pharmacy restrictions

Hospital groups are asking Congress to do a better job of overseeing the 340B drug discount program, and they are calling on lawmakers to step

August 8, 2023

Phase III trials indicate reversible cognitive side effects in brain metastases treatment

A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled

September 30, 2024

Building a Supportive Infrastructure for the Emerging Psychedelic Industry | Psychedelic Invest

As the psychedelic space expands rapidly and exponentially, there is a dire need for infrastructure to support the needs of the industry. Psychedelics have unique

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.